Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial. 2023

Publication Date

6-2-2023

Presented At:

ASCO Annual Meeting

Content Type

Presentation

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS